Get Ready for More Statin Hype: A trial in Britain that looked at heart attack rates in men with high blood pressure but normal cholesterol who were given Lipitor ( a cholesterol-lowering drug in the statin class) has been halted because the researchers felt the drug was so advantageous:

Among the 5,000 patients who took atorvastatin, the risk of heart attacks or stroke was cut by a third.

The story doesn't mention what the absolute numbers were. That could be a reduction from 3% to 1%, or it could be from 30% to 10%. The study hasn't been published yet, but I'm sure that we'll soon be urged to put everyone with high blood pressure on Lipitor, regardless of how great or small the magnitude of change actually is. Stay tuned....